Log In
Print
BCIQ
Print
Print this Print this
 

Juvederm Voluma XC

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionFormulation of hyaluronic acid injectable gel biosynthesized with Streptococcus equi that includes the anesthetic lidocaine.
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsDeep injection for cheek augmentation to correct age-related volume deficit in the mid-face
Regulatory Designation

U.S. - Undisclosed Review (Deep injection for cheek augmentation to correct age-related volume deficit in the mid-face)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today